Patients with aggressive type of breast cancer can look forward to cheaper medicines

By LOH FOON FONG
  • Nation

  • Monday, 10 Dec 2018

PETALING JAYA: Good news for patients who could not afford an exorbitant medicine for an aggressive type of breast cancer.

The Health Ministry has approved the biosimilar version of trastuzumab (a monoclonal antibody), a targeted therapy, for women with HER2-positive breast cancer patients, said Dr Dzulkefly Ahmad.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Nation
Student surrendered package with Zara Qairina's notes, testifies ex-head warden
VAT 69 commando death in training exercise being investigated, says IGP
EC begins distributing polling equipment for Kinabatangan, Lamag by-elections
Vote Warisan to strengthen central–east Sabah’s voice in Parliament, says Shafie
Base MHIT plan may offer medical coverage from RM50 a month
Locals protest suggestion to rename Jalan Pantai Bersih
MACC detains six company owners, freezes RM7.2mil in e-waste cases
Malaysia lost 47,250 football fields worth of its coral reefs in last three years
Police foil RM80.3mil drug haul destined for Australia
MCMC records statements of China Press editor-in-chief, online editor

Trending in News

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.